Chemo- or endocrine adjuvant therapy alone or combined in postmenopausal patients (GABG Trial 1).
作者信息
Jonat W, Kaufmann M, Abel U
机构信息
Abteilung für Gynäkologie und Geburtshilfe, Universitätsklinik Hamburg, FRG.
出版信息
Recent Results Cancer Res. 1989;115:163-9. doi: 10.1007/978-3-642-83337-3_23.
PMID:2696028
Abstract
摘要
相似文献
1
Chemo- or endocrine adjuvant therapy alone or combined in postmenopausal patients (GABG Trial 1).绝经后患者单独或联合使用化疗或内分泌辅助治疗（GABG试验1）。
Recent Results Cancer Res. 1989;115:163-9. doi: 10.1007/978-3-642-83337-3_23.
2
Adjuvant chemo- and endocrine therapy alone or in combination in premenopausal patients (GABG Trial 1).绝经前患者单独或联合使用辅助化疗和内分泌治疗（GABG试验1）。
Recent Results Cancer Res. 1989;115:118-25. doi: 10.1007/978-3-642-83337-3_17.
3
Adjuvant chemo-endocrine therapy or endocrine therapy alone for postmenopausal patients: Ludwig Studies III and IV.绝经后患者的辅助化疗-内分泌治疗或单纯内分泌治疗：路德维希研究III和IV。
Recent Results Cancer Res. 1989;115:153-62. doi: 10.1007/978-3-642-83337-3_22.
4
Ludwig Breast Cancer trial LBCS III: chemo- and endocrine adjuvant treatment in postmenopausal patients.路德维希乳腺癌试验LBCS III：绝经后患者的化疗和内分泌辅助治疗。
Recent Results Cancer Res. 1984;96:102-9. doi: 10.1007/978-3-642-82357-2_12.
5
Significant survival benefit of node-negative breast cancer patients treated with adjuvant chemotherapy: seven-year results.辅助化疗治疗的淋巴结阴性乳腺癌患者具有显著生存获益：七年结果
Recent Results Cancer Res. 1989;115:180-5. doi: 10.1007/978-3-642-83337-3_26.
6
Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.化疗内分泌与内分泌辅助治疗用于淋巴结阴性乳腺癌的比较：雌激素和孕激素受体中心评估表达的预测价值——国际乳腺癌研究组
J Clin Oncol. 2008 Mar 20;26(9):1404-10. doi: 10.1200/JCO.2007.10.6393.
7
Adjuvant chemotherapy for node-negative breast cancer patients.淋巴结阴性乳腺癌患者的辅助化疗。
Recent Results Cancer Res. 1989;115:175-9. doi: 10.1007/978-3-642-83337-3_25.
8
Hormone receptors. An update and application.激素受体。最新进展与应用。
Surg Clin North Am. 1984 Dec;64(6):1155-72. doi: 10.1016/s0039-6109(16)43487-0.
9
Ludwig Breast Cancer trials LBCS III and IV: adjuvant endocrine treatment in postmenopausal patients.路德维希乳腺癌试验LBCS III和IV：绝经后患者的辅助内分泌治疗。
Recent Results Cancer Res. 1984;96:204-9. doi: 10.1007/978-3-642-82357-2_26.
10
Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, estrogen receptor-positive breast cancer patients: results of a multicentric Italian study. Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group.在淋巴结阳性、雌激素受体阳性乳腺癌患者中，化疗与他莫昔芬及化疗加他莫昔芬的比较：一项意大利多中心研究结果。乳腺癌辅助化疗-激素治疗协作组
J Clin Oncol. 1990 Aug;8(8):1310-20. doi: 10.1200/JCO.1990.8.8.1310.
Zotero 插件